Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Denmark's Novo Nordisk accepts fine for late disclosure of drug setback
Yahoo/Reuters
Monday, August 18, 2014 - 11:55am
tags:
Novo Nordisk, Ryzodeg, Tresiba
Biogen Idec: Drug Approval Offers ‘Underappreciated Earnings Upside,” Morgan Stanley Says
Barron's
Monday, August 18, 2014 - 11:52am
tags:
earnings, Biogen Idec, MS, multiple sclerosis, Plegridy
Most Popular News Headlines For Friday/Saturday August 15-16 2014
CP Wire
Monday, August 18, 2014 - 11:48am
tags:
Pfizer, FDA, Eisai, Amgen, Gilead, Sovaldi, Roche, DEA, Repligen, drug manufacturing
Cubist Battling Superbugs Offers Remedy for J&J: Real M&A
Bloomberg
Monday, August 18, 2014 - 11:04am
tags:
JNJ, M&A, Cubist Pharmaceuticals, antibiotics, superbugs
[video] Is a Roche-Chugai merger on the cards?
CNBC
Monday, August 18, 2014 - 10:27am
tags:
Roche, Chugai, M&A
Pfizer Announces Submission of Palbociclib New Drug Application to the FDA
Yahoo
Monday, August 18, 2014 - 9:37am
tags:
Pfizer, palbociclib, FDA, breast cancer
Japan’s Eisai Steps Up Push in Cancer Drugs
WSJ Online
Monday, August 18, 2014 - 9:32am
tags:
Japan, Eisai, thyroid cancer, Lenvatinib
UK Says Sovaldi Is Worth It. We Should Listen.
Forbes
Monday, August 18, 2014 - 9:20am
tags:
UK, Sovaldi, hepatitis C, Gilead Sciences
Extreme medicine: The search for new antibiotics
Yahoo/Reuters
Sunday, August 17, 2014 - 9:47am
tags:
antibiotics
Pfizer is Liable for Harm Caused by a Generic Version of its Drug: Court
WSJ Pharmalot
Saturday, August 16, 2014 - 4:46pm
tags:
Pfizer, generics, Reglan
Unfair!! Eisai Sues FDA to Regain ‘Lost’ Marketing Time for its Drugs
WSJ Pharmalot
Saturday, August 16, 2014 - 4:45pm
tags:
FDA, Eisai, Belviq, Fycompa
Teva tries laquinimod in Huntington's after repeated MS woes
Fierce Biotech
Saturday, August 16, 2014 - 4:42pm
tags:
Huntington's disease, Teva Pharmaceutical, laquinimod
Roche weighs a $10B deal for partner Chugai
Fierce Biotech
Saturday, August 16, 2014 - 4:37pm
tags:
Roche, Chugai, M&A
Sanofi's high-dose Fluzone beats standard-dose version in protecting seniors
Fierce Vaccines
Saturday, August 16, 2014 - 4:36pm
tags:
Sanofi, vaccines, Fluzone, influenza
FDA sets decision date for Pfizer's MenB candidate
Fierce Vaccines
Saturday, August 16, 2014 - 4:35pm
tags:
FDA, Pfizer, vaccines, meningitis B, Novartis, rLP2086
Are Biosimilars Ready For Primetime?
The Morning Consult
Saturday, August 16, 2014 - 4:31pm
tags:
biosimilars
Supernus Receives FDA Fast Track Designation for SPN-810
Marketwatch
Saturday, August 16, 2014 - 4:29pm
tags:
Supernus, FDA, fast track, SPN-810, ADHD
GSK China crisis: Peter Humphrey will not appeal two-and-a-half year sentence
The Telegraph, UK
Saturday, August 16, 2014 - 8:43am
tags:
China, GSK, legal
Abbott, AbbVie Win Dismissal of Suit Over Depakote Marketing
Bloomberg
Saturday, August 16, 2014 - 8:39am
tags:
Abbott, AbbVie, Depakote
Biogen wins U.S. approval of long acting multiple sclerosis drug
Yahoo/Reuters
Saturday, August 16, 2014 - 8:35am
tags:
Biogen, MS, Plegridy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.